Howe & Rusling Inc Dynavax Technologies Corp Transaction History

Howe & Rusling Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$9.93 - $17.44 $774 - $1,360	-78 Reduced 25.74%	225 $2,000
Q1 2021 May 13, 2021	SELL	$4.57 - $11.18 $868 - $2,124	-190 Reduced 38.54%	303 $3,000
Q3 2020 Nov 06, 2020	BUY	$4.32 - $11.7 $1,438 - $3,896	333 Added 208.12%	493 $2,000
Q2 2020 Jul 15, 2020	BUY	$2.94 - $9.1 $470 - $1,456	160 New	160 $1,000

273

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.6B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.